Purposeful ^Company

Purposeful discovers new treatments and develops pharmaceutical products for rare diseases by repurposing previously marketed drugs. Their vision is to fully utilize AI repurposing and revisit rare and common diseases to reverse disease phenotypes. It collaborates with FRAXA and FRAXA-DVI to identify drug repurposing candidates for Fragile X Syndrome. They also identify drug repurposing candidates for Glioblastoma.